Brookline Capital Initiates Coverage On Eyenovia with Buy Rating, Announces Price Target of $8
Portfolio Pulse from Benzinga Newsdesk
Brookline Capital analyst Kemp Dolliver has initiated coverage on Eyenovia (NASDAQ:EYEN) with a Buy rating and announced a price target of $8.
October 17, 2023 | 3:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Brookline Capital has initiated coverage on Eyenovia with a Buy rating and a price target of $8.
The initiation of coverage by Brookline Capital with a Buy rating is a positive signal for Eyenovia. The price target of $8 indicates the analyst's confidence in the company's potential for growth. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100